Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alliance Pharmaceuticals, a wholly owned subsidiary of Alliance Pharma, has conditionally decided to acquire Reckitt Benckiser Group subsidiary's UK and Irish rights of Anbesol and Ashton & Parsons brands for around £2.55m cash consideration.
Subscribe to our email newsletter
Anbesol is indicated for the treatment of mouth ulcers, teething pains and denture irritation.
Ashton & Parsons is used in infants for the symptomatic relief of pain and stomach upset caused by teething.
The sale of the brands by Reckitt Benckiser to Alliance is conditional on the approval of the European Commission.